COMPASS Software version 3.1 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 IBA Dosimetry GmbH 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-10-23
  • 사례 출판 날짜
    2014-10-23
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: iba dosimetry gmbh compass software version 3.1 medical device manufacturer, iba dosimetry gmbh, has issued a medical device safety alert concerning its compass software version 3.1 [catalogue number: cs10-100]. based on a customer complaint the manufacturer identified that compass 3.1 has an error in the reconstruction of the dose distribution for specific plans: monaco-dmlc and eclipse imrt plans with jaw tracking- option enabled. the reconstruction results in the same dose distribution as the dose computation, which has the potential of being erroneous. based on this information the manufacturer performed a health hazard analysis for compass 3.1and determined that this failure may have an impact on the intended use of compass. the evaluation of the risk for the patient resulted in a region where a risk reduction is necessary. therefore, the affected customers have to be informed about the malfunction in the software. additionally the medical device compass 3.1 has to be corrected. affected users are advised not to apply patient plan verification for monaco-dmlc and eclipse imrt plans with jaw tracking option enabled using the 3d dose reconstruction (measurement-based) calculation method with compass 3.1 until the corrected version is available and installed. according to the manufacturer, the affected products were distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 23 october 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: [23 Oct 2014] IBA Dosimetry GmbH COMPASS Software version 3.1
  • Manufacturer

Manufacturer